Kinnate Biopharma Inc
Biotechnology
Healthcare
KNTE
46.66 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
2.36
52 week high
10.11
high
2.59
52 week low
1.34
low
2.34
growth
-61.09 %
previous Close
2.37
P/E ratio
market cap
124 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-31.92 M
-2.21 %
eps
0.00 %
6.85 %
eps surprise
9.33 %
net profit margin
-3191800000.00 %
0.00 %
operating incoming
-34.14 M
1.49 %
net change in cash
-39.06 M
-310.20 %
cash on hand
34.51 M
-53.10 %
cost of revenue
0.00 %
top top